Lazari Capital Management Inc. Buys Shares of 932 UnitedHealth Group Incorporated (NYSE:UNH)

Lazari Capital Management Inc. bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 932 shares of the healthcare conglomerate's stock, valued at approximately $488,000.

A number of other institutional investors also recently modified their holdings of the stock. Palisade Asset Management LLC raised its holdings in shares of UnitedHealth Group by 2.8% during the 1st quarter. Palisade Asset Management LLC now owns 68,541 shares of the healthcare conglomerate's stock valued at $35,898,000 after purchasing an additional 1,856 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in shares of UnitedHealth Group by 6.7% during the 1st quarter. Asset Management One Co. Ltd. now owns 516,970 shares of the healthcare conglomerate's stock valued at $270,763,000 after purchasing an additional 32,612 shares in the last quarter. Foundation Wealth Management LLC PA raised its holdings in shares of UnitedHealth Group by 6.9% during the 1st quarter. Foundation Wealth Management LLC PA now owns 1,765 shares of the healthcare conglomerate's stock valued at $925,000 after purchasing an additional 114 shares in the last quarter. Walkner Condon Financial Advisors LLC raised its holdings in shares of UnitedHealth Group by 4.2% during the 1st quarter. Walkner Condon Financial Advisors LLC now owns 890 shares of the healthcare conglomerate's stock valued at $466,000 after purchasing an additional 36 shares in the last quarter. Finally, Palumbo Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 28.8% during the 1st quarter. Palumbo Wealth Management LLC now owns 7,089 shares of the healthcare conglomerate's stock valued at $3,713,000 after purchasing an additional 1,584 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $300.85 on Tuesday. The firm has a market cap of $272.91 billion, a PE ratio of 12.60, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company's 50-day moving average price is $353.44 and its two-hundred day moving average price is $460.22.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.94%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Morgan Stanley cut their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Finally, HSBC reissued a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $427.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.